Showing results (341-350 of 1,126) with videos related to
Sort By:
Pageof 113
Cancer Genetics|April 29, 2014
Prevalence of the E318K and V320I MITF germline mutations in Polish cancer patients and multiorgan cancer risk-a population-based studyTomasz Gromowski, Bartłomiej Masojć, Rodney J Scott, et al.Cancer Genetics|November 28, 2021
Classification of fluorescent R-Band metaphase chromosomes using a convolutional neural network is precise and fast in generating karyograms of hematologic neoplastic cellsBeate Vajen, Siegfried Hänselmann, Friederike Lutterloh, et al.Cancer Genetics|December 20, 2021
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinibErin R Rudzinski, Jaclyn Hechtman, Sinchita Roy-Chowdhuri, et al.Cancer Genetics|December 16, 2021
Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesisAlexandra E Kovach, Elena Zerkalenkova, Ludmila Zemtsova, et al.Cancer Genetics|November 21, 2021
Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancerAlejandra Mampel, Mayra L Sottile, Silvina P Denita-Juárez, et al.Cancer Genetics|September 3, 2019
A novel BRCA1 germline mutation promotes triple-negative breast cancer cells progression and enhances sensitivity to DNA damage agentsKun Xu, Yaqin Shi, Xin Wang, et al.Cancer Genetics|August 20, 2019
Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutationMelissa H Cessna, Prabakaran Paulraj, Benjamin Hilton, et al.Cancer Genetics|September 18, 2022
Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testingHannah Llorin, Madeline Graf, Nicolette Chun, et al.Cancer Genetics|July 13, 2015
KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasmNaery Yang, Jungwon Huh, Wha Soon Chung, et al.Cancer Genetics|August 29, 2025
Unfavorable disease progression in patients with chronic myeloid leukemia and concurrent t(6;9) translocation (DEK::NUP214 fusion) or inversion 16 (CBFB::MYH11 fusion)Ying Zhang, Jack Reid, Deepa Jeyakumar, et al.Pageof 113